These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36707842)

  • 1. Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc.
    Bellocchi C; Assassi S; Lyons M; Marchini M; Mohan C; Santaniello A; Beretta L
    Arthritis Res Ther; 2023 Jan; 25(1):15. PubMed ID: 36707842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage.
    Bellocchi C; Wang X; Lyons MA; Marchini M; Lorini M; Carbonelli V; Montano N; Assassi S; Beretta L
    Front Immunol; 2023; 14():1266391. PubMed ID: 38022564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study.
    Zumstein Camargo C; Kayser C
    Int J Rheum Dis; 2019 Jul; 22(7):1319-1326. PubMed ID: 31050209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.
    Bellocchi C; Beretta L; Wang X; Lyons MA; Marchini M; Lorini M; Carbonelli V; Montano N; Assassi S
    Rheumatology (Oxford); 2023 Apr; 62(4):1662-1668. PubMed ID: 36040182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
    Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
    Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.
    van Leeuwen NM; Boonstra M; Bakker JA; Grummels A; Jordan S; Liem S; Distler O; Hoffmann-Vold AM; Melsens K; Smith V; Truchetet ME; Scherer HU; Toes R; Huizinga TWJ; de Vries-Bouwstra JK
    Arthritis Rheumatol; 2021 Dec; 73(12):2338-2347. PubMed ID: 34042326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement.
    Valentini G; Vettori S; Cuomo G; Iudici M; D'Abrosca V; Capocotta D; Del Genio G; Santoriello C; Cozzolino D
    Arthritis Res Ther; 2012 Aug; 14(4):R188. PubMed ID: 22901779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
    Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.
    Vigone B; Santaniello A; Marchini M; Montanelli G; Caronni M; Severino A; Beretta L
    Rheumatology (Oxford); 2015 Apr; 54(4):707-11. PubMed ID: 25231181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
    Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
    J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.
    Jiang Z; Chen C; Yang S; He H; Zhu X; Liang M
    J Dermatol Sci; 2021 Oct; 104(1):63-73. PubMed ID: 34556381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
    Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
    Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis.
    Motta F; Tonutti A; Isailovic N; Ceribelli A; Costanzo G; Rodolfi S; Selmi C; De Santis M
    Front Immunol; 2023; 14():1246777. PubMed ID: 37753072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
    Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
    Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
    Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
    Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.
    Zheng B; Vincent C; Fritzler MJ; Senécal JL; Koenig M; Joyal F
    J Rheumatol; 2017 Jan; 44(1):33-39. PubMed ID: 27744398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.